 | Up a level |
Barrow, M, Taylor, A 
ORCID: 0000-0003-2028-6694, García Carrión, J, Mandal, P, Park, BK ORCID: 0000-0001-8384-824X, Poptani, H ORCID: 0000-0002-0593-3235, Murray, P, Rosseinsky, MJ ORCID: 0000-0002-1910-2483 and Adams, DJ
(2016)
Co-precipitation of DEAE-dextran coated SPIONs: how synthesis conditions affect particle properties, stem cell labelling and MR contrast.
Contrast media & molecular imaging, 11 (05).
pp. 362-370.
Mohan, S, Wang, S, Coban, G, Kural, F, Chawla, S, O'Rourke, DM and Poptani, H ORCID: 0000-0002-0593-3235
(2019)
Detection of occult neoplastic infiltration in the corpus callosum and prediction of overall survival in patients with glioblastoma using diffusion tensor imaging.
European Journal of Radiology, 112.
pp. 106-111.
Chawla, S, Loevner, LA, Kim, SG, Hwang, W-T, Wang, S, Verma, G, Mohan, S, LiVolsi, V, Quon, H and Poptani, H ORCID: 0000-0002-0593-3235
(2018)
Dynamic Contrast-Enhanced MRI-Derived Intracellular Water Lifetime (tau(i)): A Prognostic Marker for Patients with Head and Neck Squamous Cell Carcinomas.
AMERICAN JOURNAL OF NEURORADIOLOGY, 39 (1).
pp. 138-144.
Wilson, M, Andronesi, O, Barker, PB, Bartha, R, Bizzi, A, Bolan, PJ, Brindle, KM, Choi, IY, Cudalbu, C, Dydak, U et al (show 39 more authors)
(2019)
Methodological consensus on clinical proton MRS of the brain: Review and recommendations.
Magnetic Resonance in Medicine, 82 (2).
pp. 527-550.
Mohan, S, Chawla, S, Skolnik, A and Poptani, H ORCID: 0000-0002-0593-3235
(2016)
Perspective on the EF-14 trial and its implications for the role of tumor-treating fields in the management of glioblastoma.
TRANSLATIONAL CANCER RESEARCH, 5 (S2).
S272-S275.